MOTS-C Australia
MOTS-C research peptide available in Australia for laboratory research purposes. A mitochondria-derived peptide studied in metabolic regulation and longevity research, with batch-specific laboratory documentation available.
Current batch: 20260729
Select strength
Price
$79 AUD
Laboratory documentation
Batch Testing
Current batch
20260729
Laboratory
Not stated in report
Test date
26 July 2026
Reported purity
99.21%
Testing is arranged by Pepy and performed by independent third-party laboratories. Reports apply only to the batch shown.
View original PDFCatalogue information
Product Details
- Compound
- MOTS-C
- Strength
- 10mg
- Research classification
- Metabolic
Catalogue description
Research Information
MOTS-C is a mitochondria-derived peptide supplied in 10mg strength. Its research classification centres on mitochondrial and cellular-energy signalling, with existing Pepy information identifying metabolic and AMPK-associated pathways as relevant areas of study. A current report documents the particular MOTS-C batch identified on this page.
Compound data
| CAS number | 1627580-64-6 |
|---|---|
| Molecular formula | C101H152N28O22S2 |
| Molecular weight | 2174.6 g/mol |
| Sequence | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| PubChem CID | 146675088 |
| Last reviewed: | 20 Oct 2026 |